サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1269673

自閉スペクトラム症（ASD）治療の世界市場規模調査＆予測、薬物クラス別、タイプ別、流通チャネル別、地域別分析、2022-2029年

Global Autism Spectrum Disorders Treatment Market Size Study & forecast, by Drug Class by Type, by Distribution Channel and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.76円
自閉スペクトラム症（ASD）治療の世界市場規模調査＆予測、薬物クラス別、タイプ別、流通チャネル別、地域別分析、2022-2029年
出版日: 2023年05月05日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

自閉スペクトラム症（ASD）治療の世界市場は、2021年に約18億5,000万米ドルと評価され、予測期間2022-2029年には7.4％以上の健全な成長率で成長すると予測されています。

自閉スペクトラム症（ASD）は、社会的相互作用、コミュニケーション、行動に影響を及ぼす神経発達障害の一つです。症状や重症度が個人によって大きく異なるため、スペクトラム障害と呼ばれています。ASDは通常、幼児期に診断されますが、人生の後半になるまで発見されないこともあります。ASDの一般的な症状としては、社会的相互作用やコミュニケーションの困難さ、反復行動、特定の興味や話題に強く集中することなどが挙げられます。市場の成長を支える主な要因は、世界の自閉スペクトラム症（ASD）の負担増、ASDに関連する意識の高まり、投資件数の増加であり、さまざまな財団の設立や各国の自閉症啓発のためのさまざまな資金の認可といった政府の取り組みの増加は、予測期間中に市場に有利な需要を生み出すと予測されています。

しかし、自閉スペクトラム症（ASD）治療市場の成長は、自閉スペクトラム症（ASD）の有病率の上昇とASDの診断率の上昇によってもたらされます。例えば、世界保健機関（WHO）は、2022年3月には、世界の子どもの100人に1人が自閉スペクトラム症に罹患すると推定しています。ASDを理解し管理するためには、早期発見が不可欠です。多くの調査によると、診断の平均年齢は3歳から6歳で、社会経済的なレベルや民族的な背景によってかなりの差があるようです。また、自閉スペクトラム症の治療法の進歩のための研究開発活動の活発化、新製品の開発および製品認可は、予測期間中に市場に有利な機会をもたらすと予想されます。しかし、自閉スペクトラム症の治療と診断にかかる費用が高く、製品承認に関わる規制が厳しいため、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

自閉スペクトラム症（ASD）治療の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他の地域です。北米は、主要な市場プレイヤーの存在、米国における自閉症疾患の有病率の増加、治療法の普及・浸透により、市場シェアにおいて世界の主要な地域となっています。一方、アジア太平洋地域は、効果的な治療法に対する需要の高まりなどの要因により、予測期間中に最も高い成長率を示すと予想されています。病院などの設備が整った医療機関へのニーズを満たすためのヘルスケアインフラの整備は、アジア太平洋地域の自閉スペクトラム症（ASD）治療市場に有利な成長見通しをもたらすと考えられます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 自閉スペクトラム症（ASD）治療市場、地域別、2019-2029年
    • 自閉スペクトラム症（ASD）治療市場、薬効クラス別、2019-2029年
    • 自閉スペクトラム症（ASD）治療市場、タイプ別、2019-2029年
    • 自閉スペクトラム症（ASD）治療市場、流通チャネル別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 世界の自閉スペクトラム症（ASD）治療市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 自閉スペクトラム症（ASD）治療の世界市場力学

  • 自閉スペクトラム症（ASD）治療市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 世界的に増加する自閉スペクトラム症（ASD）の負担増
      • ASDに関する認知度の向上と投資件数の増加
    • 市場の課題
      • 自閉スペクトラム症（ASD）治療・診断にかかる高額な費用について
      • 製品承認に関わる厳しい規制
    • 市場機会
      • 自閉スペクトラム症の治療法の進歩に向けた研究開発活動の活発化

第4章 自閉スペクトラム症（ASD）治療の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 主な投資機会
  • 主要成功戦略
  • 業界関係者見通し
  • アナリストの提言と結論

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 自閉スペクトラム症（ASD）治療の世界市場：薬物クラス別

  • マーケットスナップショット
  • 自閉スペクトラム症（ASD）治療の世界市場：薬物クラス別、業績-潜在能力分析
  • 自閉スペクトラム症（ASD）治療の世界市場薬剤クラス別推定・予測2019-2029
  • 自閉スペクトラム症（ASD）治療市場、サブセグメント分析
    • 抗精神病薬
    • SSRI/抗うつ剤
    • 覚醒剤
    • その他

第7章 自閉スペクトラム症（ASD）治療の世界市場：タイプ別

  • マーケットスナップショット
  • 自閉スペクトラム症（ASD）治療の世界市場：タイプ別、実績-潜在的分析
  • 自閉スペクトラム症（ASD）治療の世界市場タイプ別推定・予測2019-2029
  • 自閉スペクトラム症（ASD）治療市場、サブセグメント分析
    • 自閉症
    • アスペルガー症候群
    • その他のタイプ

第8章 自閉スペクトラム症（ASD）治療の世界市場：流通チャネル別

  • マーケットスナップショット
  • 自閉スペクトラム症（ASD）治療の世界市場：流通チャネル別、業績-潜在能力分析
  • 自閉スペクトラム症（ASD）治療の世界市場流通チャネル別推定・予測2019-2029
  • 自閉スペクトラム症（ASD）治療市場、サブセグメント分析
    • 病院内薬局
    • ドラッグストア・調剤薬局
    • オンライン薬局

第9章 自閉スペクトラム症（ASD）治療の世界市場：地域別分析

  • 自閉スペクトラム症（ASD）治療市場、地域別マーケットスナップショット
  • 北米
    • 米国
      • 薬剤クラス別の推定・予測、2019年～2029年
      • タイプ別の推定・予測、2019年～2029年
      • 流通チャネル別の推定・予測、2019年～2029年
    • カナダ
  • 欧州自閉スペクトラム症（ASD）治療市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋自閉スペクトラム症（ASD）治療市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの自閉スペクトラム症（ASD）治療市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Curemark, LLC（Rye, U.S.）
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Alembic Pharmaceuticals Limited（Vadodara, India）
    • Yamo Pharmaceuticals（New York, U.S.）
    • PaxMedica, Inc.（Woodcliff Lake, U.S.）
    • F. Hoffmann-La Roche Ltd（Basel, Switzerland）
    • Aurobindo Pharma Ltd.（Hyderabad, India）
    • Otsuka Holdings Co. Ltd.（Tokyo, Japan）
    • Janssen Pharmaceuticals, Inc.（Titusville, New Jersey）
    • Teva Pharmaceutical Industries Ltd.（Tel Aviv, Israel）
    • H. Lundbeck A/S（Copenhagen, Denmark）

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Autism Spectrum Disorders Treatment Market, report scope
  • TABLE 2. Global Autism Spectrum Disorders Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Autism Spectrum Disorders Treatment Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
  • TABLE 4. Global Autism Spectrum Disorders Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 5. Global Autism Spectrum Disorders Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Autism Spectrum Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Autism Spectrum Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Autism Spectrum Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Autism Spectrum Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Autism Spectrum Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Autism Spectrum Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Autism Spectrum Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Autism Spectrum Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Autism Spectrum Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Autism Spectrum Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Autism Spectrum Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Autism Spectrum Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Autism Spectrum Disorders Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Autism Spectrum Disorders Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Autism Spectrum Disorders Treatment Market, research methodology
  • FIG 2. Global Autism Spectrum Disorders Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Autism Spectrum Disorders Treatment Market, key trends 2021
  • FIG 5. Global Autism Spectrum Disorders Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Autism Spectrum Disorders Treatment Market, porters 5 force model
  • FIG 7. Global Autism Spectrum Disorders Treatment Market, pest analysis
  • FIG 8. Global Autism Spectrum Disorders Treatment Market, value chain analysis
  • FIG 9. Global Autism Spectrum Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Autism Spectrum Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Autism Spectrum Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Autism Spectrum Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Autism Spectrum Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Autism Spectrum Disorders Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Autism Spectrum Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Autism Spectrum Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Autism Spectrum Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Autism Spectrum Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Autism Spectrum Disorders Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Autism Spectrum Disorders Treatment Market is valued at approximately USD 1.85 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder that affects social interaction, communication, and behavior. It is called a spectrum disorder because the symptoms and severity can vary widely among individuals. ASD is typically diagnosed in early childhood, but sometimes it is not identified until later in life. Some common symptoms of ASD include difficulties with social interactions and communication, repetitive behaviors, and a strong focus on specific interests or topics. The key factor supporting the market growth is the rising burden of autism spectrum disorder (ASD) globally, growing awareness pertaining to ASD and rising number of investments, and the growing number of government initiatives such as forming various foundations and sanctioning different funding for the awareness of autism in various countries is anticipated to create the lucrative demand for the market during the forecast period.

However, Autism Spectrum Disorders Treatment Market Growth is driven by the rising prevalence of autism spectrum disorder (ASD) and the rising diagnostic rate of ASD. For instance, the World Health Organization (WHO) estimates that in March 2022, one in 100 children globally will have autism spectrum disorder. Early detection of ASD is essential to comprehending and managing the condition. According to numerous research, the average age of diagnosis is between 3 and 6 years old, with considerable variations depending on the socioeconomic level and ethnic origin. Additionally, rising R&D activity for advancements in autism spectrum disorder treatment, and new product development and product approvals are anticipated to create a lucrative opportunity for the market during the forecast period. However, the high cost of autism spectrum disorder treatment and diagnosis and stringent regulations pertaining to product approval stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Autism Spectrum Disorders Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, the growing prevalence of autism disorder across the U.S., coupled with the growing adoption and uptake of therapies. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as rising demand for effective treatment. The development of healthcare infrastructure to fulfil the need for well-equipped healthcare institutions such as hospitals would create lucrative growth prospects for the Autism Spectrum Disorders Treatment market across the Asia Pacific region.

Major market player included in this report are:

  • Curemark, LLC (Rye, U.S.)
  • Alembic Pharmaceuticals Limited (Vadodara, India)
  • Yamo Pharmaceuticals (New York, U.S.)
  • PaxMedica, Inc. (Woodcliff Lake, U.S.)
  • F. Hoffmann-La Roche Ltd (Basel, Switzerland)
  • Aurobindo Pharma Ltd. (Hyderabad, India)
  • Otsuka Holdings Co. Ltd. (Tokyo, Japan)
  • Janssen Pharmaceuticals, Inc. (Titusville, New Jersey)
  • Teva Pharmaceutical Industries Ltd. (Tel Aviv, Israel)
  • H. Lundbeck A/S (Copenhagen, Denmark)

Recent Developments in the Market:

  • In Oct. 2021, Axial Therapeutics reported that the FDA approved the company's Investigational New Drug (IND) application for its lead product, AB-2004, a molecular therapy that is being investigated for the treatment of irritability associated with ASD.

Global Autism Spectrum Disorders Treatment Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Drug Class, Type, Distribution Channel, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Class:

  • Antipsychotic Drugs
  • SSRIs/Antidepressants
  • Stimulants
  • Other Drug Classes

By Type:

  • Autistic Disorder
  • Asperger's Syndrome
  • Other Types

By Distribution Channel:

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Autism Spectrum Disorders Treatment Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Autism Spectrum Disorders Treatment Market, by Drug Class, 2019-2029 (USD Billion)
    • 1.2.3. Autism Spectrum Disorders Treatment Market, by Type, 2019-2029 (USD Billion)
    • 1.2.4. Autism Spectrum Disorders Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Autism Spectrum Disorders Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Autism Spectrum Disorders Treatment Market Dynamics

  • 3.1. Autism Spectrum Disorders Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising burden of autism spectrum disorder (ASD) globally
      • 3.1.1.2. Growing awareness pertaining to ASD and rising number of investments
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of autism spectrum disorder treatment and diagnosis
      • 3.1.2.2. Stringent regulations pertaining to product approval
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising R&D activity for advancements in autism spectrum disorder treatment

Chapter 4. Global Autism Spectrum Disorders Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Autism Spectrum Disorders Treatment Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Autism Spectrum Disorders Treatment Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Autism Spectrum Disorders Treatment Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
  • 6.4. Autism Spectrum Disorders Treatment Market, Sub Segment Analysis
    • 6.4.1. Antipsychotic Drugs
    • 6.4.2. SSRIs/Antidepressants
    • 6.4.3. Stimulants
    • 6.4.4. Other Drug Classes

Chapter 7. Global Autism Spectrum Disorders Treatment Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Autism Spectrum Disorders Treatment Market by Type, Performance - Potential Analysis
  • 7.3. Global Autism Spectrum Disorders Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 7.4. Autism Spectrum Disorders Treatment Market, Sub Segment Analysis
    • 7.4.1. Autistic Disorder
    • 7.4.2. Asperger's Syndrome
    • 7.4.3. Other Types

Chapter 8. Global Autism Spectrum Disorders Treatment Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Autism Spectrum Disorders Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Autism Spectrum Disorders Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Autism Spectrum Disorders Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Drug Stores and Retail Pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Autism Spectrum Disorders Treatment Market, Regional Analysis

  • 9.1. Autism Spectrum Disorders Treatment Market, Regional Market Snapshot
  • 9.2. North America Autism Spectrum Disorders Treatment Market
    • 9.2.1. U.S. Autism Spectrum Disorders Treatment Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Autism Spectrum Disorders Treatment Market
  • 9.3. Europe Autism Spectrum Disorders Treatment Market Snapshot
    • 9.3.1. U.K. Autism Spectrum Disorders Treatment Market
    • 9.3.2. Germany Autism Spectrum Disorders Treatment Market
    • 9.3.3. France Autism Spectrum Disorders Treatment Market
    • 9.3.4. Spain Autism Spectrum Disorders Treatment Market
    • 9.3.5. Italy Autism Spectrum Disorders Treatment Market
    • 9.3.6. Rest of Europe Autism Spectrum Disorders Treatment Market
  • 9.4. Asia-Pacific Autism Spectrum Disorders Treatment Market Snapshot
    • 9.4.1. China Autism Spectrum Disorders Treatment Market
    • 9.4.2. India Autism Spectrum Disorders Treatment Market
    • 9.4.3. Japan Autism Spectrum Disorders Treatment Market
    • 9.4.4. Australia Autism Spectrum Disorders Treatment Market
    • 9.4.5. South Korea Autism Spectrum Disorders Treatment Market
    • 9.4.6. Rest of Asia Pacific Autism Spectrum Disorders Treatment Market
  • 9.5. Latin America Autism Spectrum Disorders Treatment Market Snapshot
    • 9.5.1. Brazil Autism Spectrum Disorders Treatment Market
    • 9.5.2. Mexico Autism Spectrum Disorders Treatment Market
    • 9.5.3. Rest of Latin America Autism Spectrum Disorders Treatment Market
  • 9.6. Rest of The World Autism Spectrum Disorders Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Curemark, LLC (Rye, U.S.)
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Alembic Pharmaceuticals Limited (Vadodara, India)
    • 10.2.3. Yamo Pharmaceuticals (New York, U.S.)
    • 10.2.4. PaxMedica, Inc. (Woodcliff Lake, U.S.)
    • 10.2.5. F. Hoffmann-La Roche Ltd (Basel, Switzerland)
    • 10.2.6. Aurobindo Pharma Ltd. (Hyderabad, India)
    • 10.2.7. Otsuka Holdings Co. Ltd. (Tokyo, Japan)
    • 10.2.8. Janssen Pharmaceuticals, Inc. (Titusville, New Jersey)
    • 10.2.9. Teva Pharmaceutical Industries Ltd. (Tel Aviv, Israel)
    • 10.2.10. H. Lundbeck A/S (Copenhagen, Denmark)

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption